Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-5 of 5 for your search:
Drug:
tariquidar
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Randomized Study of Tariquidar and Docetaxel in Patients With Recurrent or Metastatic Lung, Ovarian, Cervical Cancer, or Renal Cell Carcinoma (no longer accruing patients with ovarian or lung cancer as of 3/01/06)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-03-C-0284
, NCT00072202
2.
Phase II Study of Combination Chemotherapy Comprising Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide and Surgery in Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-04-C-0011
, NCT00073996
3.
Phase I Study of XR9576 and Vinorelbine in Patients With Advanced Cancer (Summary Last Modified 09/2001)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-00-C-0044
4.
Phase I Study of Tariquidar Combined With Docetaxel, Doxorubicin, or Vinorelbine in Children With Relapsed or Refractory Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
2 to 18
Sponsor:
NCI
Protocol IDs:
NCI-01-C-0091I
, NCT00020514
5.
Diagnostic Pilot Study of Positron-Emission Tomography Imaging Using Tariquidar as a Drug Resistance Inhibitor and Technetium Tc 94m Sestamibi in Patients With Cancer
Phase:
No phase specified
Type:
Diagnostic
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-04-C-0177
, NCT00086853
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute